Arcellx (ACLX) Revenue (2023 - 2025)

Arcellx's quarterly Revenue came in at $1.7 million in Q4 2025, down 89.17% year-on-year from $15.3 million in Q4 2024, and down 66.24% quarter-over-quarter from $4.9 million in Q3 2025.

Arcellx has reported Revenue for 3 years, with the latest figure at $1.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Revenue fell 89.17% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $22.3 million (down 79.36% YoY), and the FY2025 full-year result was $22.3 million, down 79.35% from the prior year.
  • Revenue for Q4 2025 stood at $1.7 million, down from $4.9 million in the prior quarter.
  • The five-year high for Revenue was $63.1 million in Q4 2023, with the low at $1.7 million in Q4 2025.
  • Average Revenue over 3 years is $20.0 million, with a median of $15.1 million recorded in 2023.
  • Year-over-year, Revenue jumped 119.16% in 2024 and plunged 89.17% in 2025.
  • Tracing ACLX's Revenue over 3 years: stood at $63.1 million in 2023, then sank by 75.83% to $15.3 million in 2024, then sank by 89.17% to $1.7 million in 2025.
  • The last three Revenue figures came in at $1.7 million (Q4 2025), $4.9 million (Q3 2025), and $7.6 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 306.30 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 2.99 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 3.61 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.17 Bn
10 Arcellx 6.48 Bn 6.48 Bn - 1.65 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.65 Mn
Sep 30, 2025 4.90 Mn
Jun 30, 2025 7.60 Mn
Mar 31, 2025 8.13 Mn
Dec 31, 2024 15.27 Mn
Sep 30, 2024 26.03 Mn
Jun 30, 2024 27.38 Mn
Mar 31, 2024 39.26 Mn
Dec 31, 2023 63.15 Mn
Sep 30, 2023 14.96 Mn
Jun 30, 2023 14.30 Mn
Mar 31, 2023 17.91 Mn